{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T04:11:58Z","timestamp":1729570318979,"version":"3.28.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,21]]},"DOI":"10.7759\/cureus.72005","type":"journal-article","created":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T11:37:52Z","timestamp":1729510672000},"source":"Crossref","is-referenced-by-count":0,"title":["Severe Hypertrophic Cardiomyopathy Caused by a Protein Kinase Adenosine Monophosphate-Activated Non-catalytic Subunit Gamma 2 (PRKAG2) Mutation With Refractory Chylous Effusions in a Neonate: A Case Report and Literature Review"],"prefix":"10.7759","author":[{"given":"Yohei","family":"Minamitani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayumi","family":"Oshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayo","family":"Kanai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoichi","family":"Iwamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotaka","family":"Ishido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Masutani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1161\/hc5001.102111","article-title":"Novel PRKAG2 mutation responsible for the genetic syndrome of ventricular preexcitation and conduction system disease with childhood onset and absence of cardiac hypertrophy","volume":"104","author":"Gollob MH","year":"2001","unstructured":"Gollob MH, Seger JJ, Gollob TN, Tapscott T, Gonzales O, Bachinski L, Roberts R. Novel PRKAG2 mutation responsible for the genetic syndrome of ventricular preexcitation and conduction system disease with childhood onset and absence of cardiac hypertrophy. Circulation. 2001, 104:3030-3. 10.1161\/hc5001.102111","journal-title":"Circulation"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa033349","article-title":"Glycogen storage diseases presenting as hypertrophic cardiomyopathy","volume":"352","author":"Arad M","year":"2005","unstructured":"Arad M, Maron BJ, Gorham JM, et al.. Glycogen storage diseases presenting as hypertrophic cardiomyopathy. N Engl J Med. 2005, 352:362-72. 10.1056\/NEJMoa033349","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1203\/PDR.0b013e3181462b86","article-title":"Fatal infantile cardiac glycogenosis with phosphorylase kinase deficiency and a mutation in the gamma2-subunit of AMP-activated protein kinase","volume":"62","author":"Akman HO","year":"2007","unstructured":"Akman HO, Sampayo JN, Ross FA, et al.. Fatal infantile cardiac glycogenosis with phosphorylase kinase deficiency and a mutation in the gamma2-subunit of AMP-activated protein kinase. Pediatr Res. 2007, 62:499-504. 10.1203\/PDR.0b013e3181462b86","journal-title":"Pediatr Res"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGEN.119.002748","article-title":"Genetic testing for diagnosis of hypertrophic cardiomyopathy mimics: yield and clinical significance","volume":"13","author":"Hoss S","year":"2020","unstructured":"Hoss S, Habib M, Silver J, et al.. Genetic testing for diagnosis of hypertrophic cardiomyopathy mimics: yield and clinical significance. Circ Genom Precis Med. 2020, 13:e002748. 10.1161\/CIRCGEN.119.002748","journal-title":"Circ Genom Precis Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-20-0524","article-title":"Hypertrophic cardiomyopathy - a heterogeneous and lifelong disease in the real world","volume":"84","author":"Kitaoka H","year":"2020","unstructured":"Kitaoka H, Kubo T, Doi YL. Hypertrophic cardiomyopathy - a heterogeneous and lifelong disease in the real world. Circ J. 2020, 84:1218-26. 10.1253\/circj.CJ-20-0524","journal-title":"Circ J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00813.2016","article-title":"A novel, de novo mutation in the PRKAG2 gene: infantile-onset phenotype and the signaling pathway involved","volume":"313","author":"Xu Y","year":"2017","unstructured":"Xu Y, Gray A, Hardie DG, et al.. A novel, de novo mutation in the PRKAG2 gene: infantile-onset phenotype and the signaling pathway involved. Am J Physiol Heart Circ Physiol. 2017, 313:283-92. 10.1152\/ajpheart.00813.2016","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2016.09.006","article-title":"Alglucosidase alfa enzyme replacement therapy as a therapeutic approach for a patient presenting with a PRKAG2 mutation","volume":"120","author":"Austin SL","year":"2017","unstructured":"Austin SL, Chiou A, Sun B, Case LE, Govendrageloo K, Hansen P, Kishnani PS. Alglucosidase alfa enzyme replacement therapy as a therapeutic approach for a patient presenting with a PRKAG2 mutation. Mol Genet Metab. 2017, 120:96-100. 10.1016\/j.ymgme.2016.09.006","journal-title":"Mol Genet Metab"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102723","article-title":"Identification, clinical manifestation and structural mechanisms of mutations in AMPK associated cardiac glycogen storage disease","volume":"54","author":"Hu D","year":"2020","unstructured":"Hu D, Hu D, Liu L, et al.. Identification, clinical manifestation and structural mechanisms of mutations in AMPK associated cardiac glycogen storage disease. EBioMedicine. 2020, 54:102723. 10.1016\/j.ebiom.2020.102723","journal-title":"EBioMedicine"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1657763","article-title":"Infantile onset hypertrophic cardiomyopathy secondary to PRKAG2 gene mutation is associated with poor prognosis","volume":"7","author":"Gorla SR","year":"2018","unstructured":"Gorla SR, Raja KR, Garg A, Barbouth DS, Rusconi PG. Infantile onset hypertrophic cardiomyopathy secondary to PRKAG2 gene mutation is associated with poor prognosis. J Pediatr Genet. 2018, 7:180-4. 10.1055\/s-0038-1657763","journal-title":"J Pediatr Genet"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1086\/430840","article-title":"Fatal congenital heart glycogenosis caused by a recurrent activating R531Q mutation in the gamma 2-subunit of AMP-activated protein kinase (PRKAG2), not by phosphorylase kinase deficiency","volume":"76","author":"Burwinkel B","year":"2005","unstructured":"Burwinkel B, Scott JW, B\u00fchrer C, et al.. Fatal congenital heart glycogenosis caused by a recurrent activating R531Q mutation in the gamma 2-subunit of AMP-activated protein kinase (PRKAG2), not by phosphorylase kinase deficiency. Am J Hum Genet. 2005, 76:1034-49. 10.1086\/430840","journal-title":"Am J Hum Genet"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00246-009-9521-3","article-title":"Severe hypertrophic cardiomyopathy in an infant with a novel PRKAG2 gene mutation: potential differences between infantile and adult onset presentation","volume":"30","author":"Kelly BP","year":"2009","unstructured":"Kelly BP, Russell MW, Hennessy JR, Ensing GJ. Severe hypertrophic cardiomyopathy in an infant with a novel PRKAG2 gene mutation: potential differences between infantile and adult onset presentation. Pediatr Cardiol. 2009, 30:1176-9. 10.1007\/s00246-009-9521-3","journal-title":"Pediatr Cardiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-017-0072-0","article-title":"PRKAG2 mutations presenting in infancy","volume":"40","author":"Torok RD","year":"2017","unstructured":"Torok RD, Austin SL, Phornphutkul C, et al.. PRKAG2 mutations presenting in infancy. J Inherit Metab Dis. 2017, 40:823-30. 10.1007\/s10545-017-0072-0","journal-title":"J Inherit Metab Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-86338-4","article-title":"Clinical and genetic spectrum of glycogen storage disease in Iranian population using targeted gene sequencing","volume":"11","author":"Beyzaei Z","year":"2021","unstructured":"Beyzaei Z, Ezgu F, Geramizadeh B, et al.. Clinical and genetic spectrum of glycogen storage disease in Iranian population using targeted gene sequencing. Sci Rep. 2021, 11:7040. 10.1038\/s41598-021-86338-4","journal-title":"Sci Rep"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.1962","article-title":"Controversial molecular functions of CBS versus non-CBS domain variants of PRKAG2 in arrhythmia and cardiomyopathy: a case report and literature review","volume":"10","author":"Gong X","year":"2022","unstructured":"Gong X, Yu P, Wu T, et al.. Controversial molecular functions of CBS versus non-CBS domain variants of PRKAG2 in arrhythmia and cardiomyopathy: a case report and literature review. Mol Genet Genomic Med. 2022, 10:e1962. 10.1002\/mgg3.1962","journal-title":"Mol Genet Genomic Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.63865","article-title":"PRKAG2\u2010related lethal congenital glycogen storage disease of the heart as rare cause of fetal hydrops with bradycardia and cardiomyopathy: clinical report and literature review","volume":"2024","author":"White-Brown AM","year":"2024","unstructured":"White-Brown AM, Richard M, Morency AM, Maedler-Kron C, De Bie I. PRKAG2\u2010related lethal congenital glycogen storage disease of the heart as rare cause of fetal hydrops with bradycardia and cardiomyopathy: clinical report and literature review. Am J Med Genet A. 2024, 2024:e63865. 10.1002\/ajmg.a.63865","journal-title":"Am J Med Genet A"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1053\/j.sempedsurg.2014.09.011","article-title":"Chylothorax and chylous ascites: management and pitfalls","volume":"23","author":"Lopez-Gutierrez JC","year":"2014","unstructured":"Lopez-Gutierrez JC, Tovar JA. Chylothorax and chylous ascites: management and pitfalls. Semin Pediatr Surg. 2014, 23:298-302. 10.1053\/j.sempedsurg.2014.09.011","journal-title":"Semin Pediatr Surg"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(87)90267-0","article-title":"Treatment of chronic pleural effusions after the Fontan procedure with prednisone","volume":"60","author":"Rothman A","year":"1987","unstructured":"Rothman A, Mayer JE, Freed MD. Treatment of chronic pleural effusions after the Fontan procedure with prednisone. Am J Cardiol. 1987, 60:408-9. 10.1016\/0002-9149(87)90267-0","journal-title":"Am J Cardiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.1992.02160240063021","article-title":"Spontaneous chylothorax in Noonan syndrome. Treatment with prednisone","volume":"146","author":"Goens MB","year":"1992","unstructured":"Goens MB, Campbell D, Wiggins JW. Spontaneous chylothorax in Noonan syndrome. Treatment with prednisone. Am J Dis Child. 1992, 146:1453-6. 10.1001\/archpedi.1992.02160240063021","journal-title":"Am J Dis Child"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.29510","article-title":"Sirolimus efficacy in the treatment of critically ill infants with congenital primary chylous effusions","volume":"69","author":"Agarwal S","year":"2022","unstructured":"Agarwal S, Anderson BK, Mahajan P, Fernandes CJ, Margolin JF, Iacobas I. Sirolimus efficacy in the treatment of critically ill infants with congenital primary chylous effusions. Pediatr Blood Cancer. 2022, 69:e29510. 10.1002\/pbc.29510","journal-title":"Pediatr Blood Cancer"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/304086-severe-hypertrophic-cardiomyopathy-caused-by-a-protein-kinase-adenosine-monophosphate-activated-non-catalytic-subunit-gamma-2-prkag2-mutation-with-refractory-chylous-effusions-in-a-neonate-a-case-report-and-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T11:37:53Z","timestamp":1729510673000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/304086-severe-hypertrophic-cardiomyopathy-caused-by-a-protein-kinase-adenosine-monophosphate-activated-non-catalytic-subunit-gamma-2-prkag2-mutation-with-refractory-chylous-effusions-in-a-neonate-a-case-report-and-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,21]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.72005","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,21]]}}}